Showing results (341-350 of 496) with videos related to
Sort By:
Pageof 50
Epidemiologia E Prevenzione|May 4, 2006
[The active search for occupational cancer cases: bladder cancer in Lombardy Region]Plinio Amendola, Roberto Audisio, Alessandra Scaburri, et al.Clinical and Experimental Immunology|December 9, 1998
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody statusP Invernizzi, P M Battezzati, A Crosignani, et al.Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 16, 2008
[Active search of work related tumours: preliminary findings]P Amendola, R Audisio, S Cavuto, et al.Immunology|April 28, 2007
Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infectionSilvia Della Bella, Andrea Crosignani, Antonio Riva, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 1996
Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acidM Fracchia, K D Setchell, A Crosignani, et al.American Journal of Industrial Medicine|September 16, 2011
Lung cancer risk in the electroplating industry in Lombardy, Italy, using the Italian occupational cancer monitoring (OCCAM) information systemCelestino Panizza, Edoardo Bai, Enrico Oddone, et al.International Journal of Microcirculation, Clinical and Experimental|March 1, 1995
Vascular impairment in patients with primary biliary cirrhosisB Marasini, C Pipia, G DeValle, et al.Journal of Clinical Gastroenterology|January 29, 2008
Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal studyAlberto Benetti, Andrea Crosignani, Massimo Varenna, et al.Alimentary Pharmacology & Therapeutics|April 1, 1997
Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover studyA Larghi, A Crosignani, P M Battezzati, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1989
Cabergoline: long-acting oral treatment of hyperprolactinemic disordersC Ferrari, A Mattei, G B Melis, et al.Pageof 50